| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/05/2011 | EP2269659A1 Integrin targeted imaging agents |
| 01/05/2011 | EP2269657A2 Prodrugs containing novel bio-cleavable linkers |
| 01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
| 01/05/2011 | EP2269655A2 Coupling of low molecular weight substances to hydroxyalkyl starch |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2269653A1 Composition for stabilizing -blocker, and transdermally absorbable preparation comprising the composition |
| 01/05/2011 | EP2269652A1 Composition for external application to skin |
| 01/05/2011 | EP2269651A2 Stabilisation of macrolides |
| 01/05/2011 | EP2269650A2 Carrier for enteral administration |
| 01/05/2011 | EP2269639A2 Influenza vaccine formulations for intradermal delivery |
| 01/05/2011 | EP2269638A2 Vaccine compositions comprising virosomes and a saponin adjuvant |
| 01/05/2011 | EP2269637A1 Influenza Vaccine |
| 01/05/2011 | EP2269632A2 Immunostimulatory compositions and methods of stimulating an immune response |
| 01/05/2011 | EP2269631A2 Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics |
| 01/05/2011 | EP2269605A2 Methylphenidate Modified Release Formulations |
| 01/05/2011 | EP2269599A1 Chemically stable compositions of 4-hydroxy tamoxifen and their therapeutical applications |
| 01/05/2011 | EP2269595A1 Titratable dosage transdermal delivery system |
| 01/05/2011 | EP2269593A1 Transdermally absorbable preparation |
| 01/05/2011 | EP2269592A1 Pharmaceutical composition of micronised progesterone and its use |
| 01/05/2011 | EP2269591A2 Improved pharmaceutical formulations |
| 01/05/2011 | EP2269590A2 Ion binding polymers and uses thereof |
| 01/05/2011 | EP2269589A2 Ion binding polymers and uses thereof |
| 01/05/2011 | EP2269578A2 Generation of Therapeutic Microfoam |
| 01/05/2011 | EP2269577A2 Injectable suspensions having improved injectability properties |
| 01/05/2011 | EP2269575A1 Method for improving bioavailability of latanoprost |
| 01/05/2011 | EP2269574A2 Implants for administering substances and methods of producing implants |
| 01/05/2011 | EP2269573A1 Zinc preservative composition and method of use |
| 01/05/2011 | EP2269572A1 Polymeric compositions comprising crystalline therapeutic agents and their preparations |
| 01/05/2011 | EP2268833A1 Freeze-free method for storage of polypeptides |
| 01/05/2011 | EP2268654A2 Selective high-affinity polydentate ligands and methods of making such |
| 01/05/2011 | EP2268317A2 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 01/05/2011 | EP2268315A1 Drug conjugates with polyglycerols |
| 01/05/2011 | EP2268314A2 Use of pyrene to carry peptides across the blood brain barrier |
| 01/05/2011 | EP2268313A2 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 01/05/2011 | EP2268297A1 Modified toxins |
| 01/05/2011 | EP2268282A1 Liquid formulation for deferiprone with palatable taste |
| 01/05/2011 | EP2268263A1 Improved topical ophthalmic compositions |
| 01/05/2011 | EP2178504B1 Preservative-free prostaglandin-based ophthalmic solution |
| 01/05/2011 | EP2170368B1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 01/05/2011 | EP1827501B1 Stabilized polymeric thiol reagents |
| 01/05/2011 | EP1771180B2 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 01/05/2011 | EP1765356B2 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase |
| 01/05/2011 | EP1663315B1 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells |
| 01/05/2011 | EP1485415B1 Neoplasm specific antibodies and uses thereof |
| 01/05/2011 | EP1478406B1 Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| 01/05/2011 | EP1465637B1 25-hydroxy vitamin d3 compositions |
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | EP1294769B1 Antibodies that immunospecifically bind to blys |
| 01/05/2011 | CN1933857B Conjugates of hydroxyalkyl starch and a protein |
| 01/05/2011 | CN1905866B Tulobuterol adhesive patch |
| 01/05/2011 | CN1875944B A carbowax modified stealthy liposome nanosphere of hydroxycamtothecine and preparation method thereof |
| 01/05/2011 | CN101939384A Peptide imaging agents |
| 01/05/2011 | CN101939363A Aqueous dispersion containing polysaccharide particulate gel and method for producing the same |
| 01/05/2011 | CN101939329A Amino acid pairing-based self assembling peptides and methods |
| 01/05/2011 | CN101939028A Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (PTK7) |
| 01/05/2011 | CN101939027A Lipopeptides for delivery of nucleic acids |
| 01/05/2011 | CN101939023A An orally administerable solid pharmaceutical composition and a process thereof |
| 01/05/2011 | CN101939008A Oral compositions of ABT-263 for treating cancer |
| 01/05/2011 | CN101939003A Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 01/05/2011 | CN101939002A Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 01/05/2011 | CN101938994A Bowel purgative and uses thereof |
| 01/05/2011 | CN101938993A Implantable products comprising nanoparticles |
| 01/05/2011 | CN101938992A Composition and method for assisting swallowing |
| 01/05/2011 | CN101938985A Compositions and devices |
| 01/05/2011 | CN101935407A Preparation method of superfine bacteria cellulose powder |
| 01/05/2011 | CN101935365A Method for synthesizing brain targeting head modification cyclodextrin (CD) derivative |
| 01/05/2011 | CN101935363A Method for producing pharmaceutical grade hyaluronic acid |
| 01/05/2011 | CN101935336A Method for preparing water-soluble taxane medicament and application thereof |
| 01/05/2011 | CN101934081A Magnetic nano lamellar hydroxyapatite and DNA composite as well as preparation method and application thereof |
| 01/05/2011 | CN101934080A Method for improving material blood compatibility by using electrostatic self-assembled coating |
| 01/05/2011 | CN101934079A Oral colon-specific release film coating premixed accessory of pH dependent type and preparation method thereof |
| 01/05/2011 | CN101934077A Multivalent meningococcal derivatized polysaccharide-proteinconjugates and vaccine |
| 01/05/2011 | CN101934061A Chinese medicinal chewable tables for treating diarrhea and preparation method thereof |
| 01/05/2011 | CN101934010A Plaster for treating rheumatic diseases |
| 01/05/2011 | CN101933988A Hawthorne leaf extract chewable tablet and preparation method thereof |
| 01/05/2011 | CN101933963A Nasal in-situ gel for treating headache |
| 01/05/2011 | CN101933958A Preparation method of kiwi polyphenol microcapsules |
| 01/05/2011 | CN101933949A Application of traditional Chinese medicine medicated leaven in lysozyme-liposome coated with chitosan |
| 01/05/2011 | CN101933944A Method for preparing bone peptide injection |
| 01/05/2011 | CN101933928A Method for preparing medicament for treating chicken colibacillosis |
| 01/05/2011 | CN101933922A Amino acid composition containing new antioxidant |
| 01/05/2011 | CN101933921A Composition of Doripenem and amino acid |
| 01/05/2011 | CN101933918A Sarpogrelate hydrochloride sustained-release preparation and preparation method |
| 01/05/2011 | CN101933915A Trans-dermal drug administration type Cilnidipine paster for treating hypertension and preparation method thereof |
| 01/05/2011 | CN101933914A Desloratadine patch and preparation method thereof |
| 01/05/2011 | CN101933912A Preparation technology of tryptanthrin sustained-release capsule and application thereof |
| 01/05/2011 | CN101933911A Soft capsule composition for treating senile dementia and preparation method thereof |
| 01/05/2011 | CN101933910A Mecobalamin soft capsule and preparation method thereof |
| 01/05/2011 | CN101933909A Vaccine adjuvant effervescent tablet and preparation method thereof |
| 01/05/2011 | CN101933908A Preparation process of tryptanthrin sustained release tablets and application thereof |
| 01/05/2011 | CN101933907A Novel matrix sustained-release tablet and preparation method thereof |
| 01/05/2011 | CN101933906A Preparation method of controlled-release drug-carried composite microsphere with small particle size and high mechanical strength |
| 01/05/2011 | CN101933905A Liposome composition for conveying eye treatment medicament |
| 01/05/2011 | CN101933904A Vinorelbine long circulation liposome preparation and preparation method thereof |
| 01/05/2011 | CN101933903A 油乳剂疫苗及其制备方法 Oil emulsion vaccine and its preparation method |
| 01/05/2011 | CN101933902A Granisetron hydrochloride microemulsion-based gel and preparation method thereof |
| 01/05/2011 | CN101933900A Compound preparation for preventing and treating poultry liver diseases and preparation method thereof |
| 01/05/2011 | CN101933899A Edaravone injection and preparation method thereof |
| 01/05/2011 | CN101933898A New pyritinol hydrochloride injection |
| 01/05/2011 | CN101933897A Recombinant human endostatin temperature-sensitive gel composition for injection |